Skip to main content
WGS
NASDAQ Industrial Applications And Services

GeneDx Swings to Profit, Secures $55M Blackstone Financing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$62.47
Mkt Cap
$2.015B
52W Low
$32.21
52W High
$170.87
52W Position info
94% above low
Off High info
63% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

WGS sits 94% above its 52-week low of $32.21.

Summary

GeneDx posted Q2 2026 revenue of $114.4 million, grew exome/genome volume 32%, and reached adjusted net income of $0.4 million. Full-year guidance was reaffirmed, and a $55 million financing package from Blackstone—comprising a $50 million term loan and a $5 million equity investment at $61.00 per share—was announced.


Key Events · Earnings and Guidance · WGS

  • Q2 Revenue and Volume Beat

    Revenue reached $114.4 million, with exome and genome test revenue of $100.3 million (up 17% YoY) on volume of 30,785 tests (up 32% YoY).

  • Return to Profitability

    Adjusted net income was $0.4 million, a $8.6 million improvement from Q1 2026, driven by 70% adjusted gross margin and operating expense discipline.

  • Guidance Reaffirmed and Q3 Targets Set

    Full-year 2026 revenue guidance of $475-$490 million reiterated; Q3 2026 revenue expected at $122-$124 million with adjusted net income of approximately $2 million.

  • Blackstone Financing Strengthens Balance Sheet

    Amended loan agreement adds $50 million term loan (total facility $150 million) and a $5 million equity private placement at $61.00 per share, bringing pro forma cash to ~$188 million.


Analysis · WGS · Industrial Applications And Services

A strong second quarter saw GeneDx deliver $114.4 million in revenue and a 32% year-over-year jump in exome/genome volume, flipping to adjusted net income of $0.4 million after a deep first-quarter loss. Confidence in the trajectory is underscored by reaffirmed full-year guidance and newly issued third-quarter targets. At the same time, the company expanded its term loan by $50 million and placed $5 million in equity with Blackstone at $61.00 per share—a premium to the recent stock price—lifting pro forma cash to roughly $188 million. The transaction eliminates near-term liquidity risk and validates the business model with a sophisticated life sciences investor, though the equity placement brings modest dilution.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WGS was trading at $62.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2B. The 52-week trading range was $32.21 to $170.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WGS - Latest Insights

WGS
Nov 10, 2026, 7:08 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $58.00
Real-time Price: $51.04 info
Change: -$6.97 (-12%) info
Market Cap: $1.528B info
WGS
Nov 09, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $59.00
Real-time Price: $51.04 info
Change: -$7.97 (-14%) info
Market Cap: $1.528B info
WGS
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $65.65
Real-time Price: $51.04 info
Change: -$14.62 (-22%) info
Market Cap: $1.528B info
WGS
Aug 03, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.01
Real-time Price: $51.04 info
Change: -$25.98 (-34%) info
Market Cap: $1.528B info
WGS
Aug 03, 2026, 4:12 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $60.19
Real-time Price: $51.04 info
Change: -$9.16 (-15%) info
Market Cap: $1.528B info